MCM
QGENF

Manchester Capital Management’s QIAGEN NV QGENF Stock Holding History

Manchester Capital Management’s Portfolio QGENF Stock Details QGENF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-2,155
Closed -$51K – 1113
2014
Q4 		$51K Buy
2,155
+114
+6% +$2.7K 0.01% 716
2014
Q3 		$46K Buy
+2,041
New +$46K 0.01% 745

Other funds holding QGENF

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
HJGA
Hardman Johnston Global Advisors Stamford, Connecticut $2.1B AUM 41.89% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Credit Agricole
Credit Agricole Montrouge Cedex, France $38.1B AUM
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Manchester Capital Management's QGENF Position: Q1 2015 in Review

Manchester Capital Management sold out of QIAGEN NV (QGENF) in Q1 2015, closing a stake of 2,155 shares — an estimated $51K sold.

Manchester Capital Management first reported a position in QGENF in Q3 2014 and held it in 2 quarters. The position peaked at $51K in Q4 2014. 175 funds tracked by Wall St. Rank hold QGENF as of Q1 2015.

  • Manchester Capital Management reported no remaining QIAGEN NV position as of Q1 2015 after selling out during the quarter.
  • Manchester Capital Management sold 2,155 QIAGEN NV shares in Q1 2015, an estimated $51K.
  • Manchester Capital Management first reported a position in QIAGEN NV in Q3 2014 and held it in 2 quarters.
  • Manchester Capital Management's QIAGEN NV position peaked at $51K in Q4 2014.
  • 175 funds tracked by Wall St. Rank held QIAGEN NV as of Q1 2015.

Based on Manchester Capital Management's 13F filing for Q1 2015, filed 7 May 2015.